EP1146903A4 - Glypicane zur detektion und behandlung humaner karzinome - Google Patents

Glypicane zur detektion und behandlung humaner karzinome

Info

Publication number
EP1146903A4
EP1146903A4 EP99954963A EP99954963A EP1146903A4 EP 1146903 A4 EP1146903 A4 EP 1146903A4 EP 99954963 A EP99954963 A EP 99954963A EP 99954963 A EP99954963 A EP 99954963A EP 1146903 A4 EP1146903 A4 EP 1146903A4
Authority
EP
European Patent Office
Prior art keywords
glypicans
detecting
treating human
human carcinoma
carcinoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99954963A
Other languages
English (en)
French (fr)
Other versions
EP1146903A1 (de
Inventor
Arthur Lander
Murray Korc
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Publication of EP1146903A1 publication Critical patent/EP1146903A1/de
Publication of EP1146903A4 publication Critical patent/EP1146903A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/303—Liver or Pancreas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4725—Proteoglycans, e.g. aggreccan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/04—Phosphoric diester hydrolases (3.1.4)
    • C12Y301/04011—Phosphoinositide phospholipase C (3.1.4.11)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5756—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving tumour-associated glycolinkage [TAG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP99954963A 1998-10-16 1999-10-15 Glypicane zur detektion und behandlung humaner karzinome Withdrawn EP1146903A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10451098P 1998-10-16 1998-10-16
US104510P 1998-10-16
US12162499P 1999-02-25 1999-02-25
US121624P 1999-02-25
PCT/US1999/024176 WO2000023109A1 (en) 1998-10-16 1999-10-15 Glypicans for the detection and treatment of human carcinoma

Publications (2)

Publication Number Publication Date
EP1146903A1 EP1146903A1 (de) 2001-10-24
EP1146903A4 true EP1146903A4 (de) 2005-02-16

Family

ID=26801634

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99954963A Withdrawn EP1146903A4 (de) 1998-10-16 1999-10-15 Glypicane zur detektion und behandlung humaner karzinome

Country Status (4)

Country Link
EP (1) EP1146903A4 (de)
AU (1) AU769125B2 (de)
CA (1) CA2346264A1 (de)
WO (1) WO2000023109A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2454135A1 (en) * 2001-07-12 2003-01-23 Exelixis, Inc. Gpcs as modifiers of the irrtk and p21 pathways and methods of use
WO2004022597A1 (ja) * 2002-09-04 2004-03-18 Chugai Seiyaku Kabushiki Kaisha Gpc3の血中可溶化ｎ端ﾍﾟﾌﾟﾁﾄﾞに対する抗体
MXPA04011132A (es) 2002-05-23 2005-08-15 Sunnybrook & Womens College Diagnostico de carcinoma hepatocelular.
MA40764A (fr) 2014-09-26 2017-08-01 Chugai Pharmaceutical Co Ltd Agent thérapeutique induisant une cytotoxicité
SG11201705808XA (en) * 2015-01-16 2017-08-30 Minomic Int Ltd Glypican epitopes and uses thereof
CA2983311A1 (en) * 2015-04-20 2016-10-27 Minomic International Ltd. Therapeutic antibodies and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0569367T3 (da) * 1991-01-15 1998-10-07 Biotie Therapies Oy Detektering af syndecanindhold i biologiske materialer, såsom væv og kropsvæsker, som indikationer på maligne transformatio

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
INKI P ET AL: "THE ROLE OF SYNDECAN-1 IN MALIGNANCIES", ANNALS OF MEDICINE, FINNISH MEDICAL SOCIETY DUODECIM, HELSINKI, FI, vol. 28, 1996, pages 63 - 67, XP002927348, ISSN: 0785-3890 *
SEBESTYEN A ET AL: "Expression of Syndecan-1 in Human B Cell Chronic Lymphocytic Leukaemia", EUROPEAN JOURNAL OF CANCER, PERGAMON PRESS, OXFORD, GB, vol. 33, no. 13, November 1997 (1997-11-01), pages 2273 - 2277, XP004284563, ISSN: 0959-8049 *
See also references of WO0023109A1 *
STANLEY M. ET AL, MODERN PATHOLOGY, vol. 12, no. 1, January 1999 (1999-01-01), pages 31A *
SU G. ET AL, AM J PATHOL, vol. 168, no. 6, June 2006 (2006-06-01), pages 2014 - 2026 *

Also Published As

Publication number Publication date
AU769125B2 (en) 2004-01-15
AU1118100A (en) 2000-05-08
CA2346264A1 (en) 2000-04-27
EP1146903A1 (de) 2001-10-24
WO2000023109A1 (en) 2000-04-27

Similar Documents

Publication Publication Date Title
DK0841545T3 (da) Hvirvelstrømsdetektor
FI20096273A7 (fi) Röntgenkuvauslaite
DE69510357D1 (de) Positionsdetektionsvorrichtung
DE69530817D1 (de) Positionsdetektor
DE69736849D1 (de) Objekt-Detektor
DE69507426D1 (de) Papierendedetektor
DE59812592D1 (de) Röntgengerät
DE69929237D1 (de) Strahlungsnachweisgerät
DE69516234D1 (de) Münzerfassungsvorrichtung
ID17356A (id) Pengolahan teh
DE69928361D1 (de) Strahlungsermittlungsvorrichtung
NO951890L (no) Permanent ledekileanordning
DE59813628D1 (de) Röntgendetektor
DE69908550D1 (de) Wasserzeichenerkennung
DE69840525D1 (de) Detektor zum erkennen von fehlenden impulsen
EP1146903A4 (de) Glypicane zur detektion und behandlung humaner karzinome
DE69701853D1 (de) Kantendetektion
DE69718103D1 (de) Amplitudenerfassungseinrichtung
DE69523800D1 (de) Festpunktdetektionsvorrichtung
DE69722344D1 (de) Objektdetektionsgerät
DE69509441D1 (de) Niveaudetektor
DE69709330D1 (de) Wellenleiter-photodetektoranschluss
DE69515269D1 (de) Leckdetektor
DE69739452D1 (de) Spitzenwertermittlungsgerät
FR2768632B1 (fr) Amr detection dosage seringue detection dosage

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010426

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20050105

17Q First examination report despatched

Effective date: 20080124

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100504